Patents by Inventor Franck Suzenet

Franck Suzenet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RADIOLABELLED COMPOUNDS FOR DIAGNOSING CHOLINERGIC NEURODEGENERATIVE DISEASES
    Publication number: 20240058481
    Abstract: The present invention relates to the radiolabelled compound of enantiomer (R,R) of 5-fluoro-3-4(-phenylpiperidin-1-yl)-1,2,3,4-tetrahydronaphthalen-2-ol, and to this compound for use thereof in an in vivo diagnosis method, in particular of a cholinergic neurodegenerative disease selected for example from the group formed by Alzheimer's disease, dysmnesia, learning disability, schizophrenia, cognitive dysfunction, hyperactivity disorder, anxiety neurosis, depression, analgesia and Parkinson's disease.
    Type: Application
    Filed: November 23, 2021
    Publication date: February 22, 2024
    Inventors: Sylvain ROUTIER, Frédéric BURON, Franck SUZENET, Nuno RODRIGUES, Sylvie CHALON, Johnny VERCOUILLIE, Denis GUILLOTEAU, Patrick EMOND, Hamid MARZAG
  • Polynitrogen compounds and uses thereof as fluorescent chromophores
    Patent number: 10954436
    Abstract: The present invention relates to the use, as a fluorescent chromophore, of a compound with formula (I) wherein: A1 is —N— or —C(Y1)—; A2 is —N— or —C(Y2)—; A3 is —N— or —C(Y3)—; A4 is —N— or —C(Y4)—; at least one of A1, A2, A3 and A4 representing —N—; X1 is —N— or —C(Y5)—; X2 is —N— or —C(Y6)—; X3 is —N— or —C(Y7)—; and Y1, Y2, Y3, Y4, Y5, Y6 and Y7 are in particular chosen independently of one another from the group made up of: H, electron-donor groups and electron-attracting groups.
    Type: Grant
    Filed: July 19, 2016
    Date of Patent: March 23, 2021
    Assignees: UNIVERSITE D'ORLEANS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Franck Suzenet, Doina Sirbu, Gérald Guillaumet, Pascal Bonnet
  • Compounds for using in imaging and particularly for the diagnosis of neurodegenerative diseases
    Patent number: 10906900
    Abstract: The invention relates to compounds of formula (II) for using in imaging and particularly for the diagnosis of neurodegenerative diseases.
    Type: Grant
    Filed: September 26, 2017
    Date of Patent: February 2, 2021
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE D'ORLEANS, UNIVERSITE DE TOURS, CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE TOURS, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
    Inventors: Sylvain Routier, Franck Suzenet, Sylvie Chalon, Frederic Buron, Johnny Vercouillie, Ronald Melki, Liliana Boiaryna, Denis Guilloteau, Laura Pieri
  • Lanthanide complexes based on triethylenetetramine-N,N,N?,N?,N??,N??-hexaacetic acid derivatives
    Patent number: 10669288
    Abstract: The present invention relates to a complex comprising at least one lanthanide (Ln) and at least one compound (C) comprising a unit of formula (I) below: said unit of formula (I) being covalently connected to at least one antenna which absorbs at a wavelength ranging from 500 nm to 900 nm.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: June 2, 2020
    Assignees: UNIVERSITE D'ORLEANS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Svetlana Eliseeva, Franck Suzenet, Sylvain Routier, Raja Ben Othman, Alexandra Collet, Ivana Martinic, Régis Delatouche, Stéphane Petoud
  • LANTHANIDE COMPLEXES COMPRISING DENDRIMERS
    Publication number: 20190352511
    Abstract: The present invention relates to a complex comprising at least one dendrimer and at least one lanthanide, wherein the dendrimer comprises a unit of formula (I) below: in which: C1 is a valence group 4 of formula >N—CH2—CH2—N<; A1, A2 and A3 are groups of formula —(CH2)2—C(O)—NH—(CH2)2—; the unit of formula (I) being connected covalently to at least one antenna which absorbs at a wavelength ranging from 500 nm to 900 nm.
    Type: Application
    Filed: January 10, 2018
    Publication date: November 21, 2019
    Inventors: Stéphane PETOUD, Svetlana ELISEEVA, Ivana MARTINIC, Virginie PLACIDE, Franck SUZENET, Régis DELATOUCHE, Joan LECLERC, Alexandra FOUCALT-COLLET, Guillaume COLLET
  • LANTHANIDE COMPLEXES BASED ON TRIETHYLENETETRAMINE-N,N,N',N'',N''',N'''-HEXAACETIC ACID DERIVATIVES
    Publication number: 20190330242
    Abstract: The present invention relates to a complex comprising at least one lanthanide (Ln) and at least one compound (C) comprising a unit of formula (I) below: said unit of formula (I) being covalently connected to at least one antenna which absorbs at a wavelength ranging from 500 nm to 900 nm.
    Type: Application
    Filed: January 10, 2018
    Publication date: October 31, 2019
    Inventors: Svetlana ELISEEVA, Franck SUZENET, Sylvain ROUTIER, Raja BEN OTHMAN, Alexandra COLLET, Ivana MARTINIC, Régis DELATOUCHE, Stéphane PETOUD
  • COMPOUNDS FOR USING IN IMAGING AND PARTICULARLY FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISEASES
    Publication number: 20190211011
    Abstract: The invention relates to compounds of formula (II) for using in imaging and particularly for the diagnosis of neurodegenerative diseases
    Type: Application
    Filed: September 26, 2017
    Publication date: July 11, 2019
    Inventors: Sylvain ROUTIER, Franck SUZENET, Sylvie CHALON, Frederic BURON, Johnny VERCOUILLIE, Ronald MELKI, Liliana BOIARYNA, Denis GUILLOTEAU, Laura Ronald PIERI
  • 1,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof
    Patent number: 10059704
    Abstract: A compound having the following general formula (I): wherein: X is a nitrogen atom and Y is a carbon atom; or X is a carbon atom and Y is a nitrogen atom; the Ar group is an aryl or heteroaryl group; and the RN and RN? groups, together with the carbon atoms to which they are bound, form a monocyclic or bicyclic azacycloalkane group. The pharmaceutically acceptable salts thereof, the hydrates or polymorphic crystalline structures thereof, and to the racemates, diastereoisomers, or enantiomers thereof are also described.
    Type: Grant
    Filed: April 20, 2012
    Date of Patent: August 28, 2018
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.), INSTITUT NATIONAL DE LA SANTA ET DE LA RECHERCHE MEDICALE (INSERM)
    Inventors: Sylvain Routier, Franck Suzenet, Frederic Pin, Sylvie Chalon, Johnny Vercouillie, Denis Guilloteau
  • POLYNITROGEN COMPOUNDS AND USES THEREOF AS FLUORESCENT CHROMOPHORES
    Publication number: 20180194997
    Abstract: The present invention relates to the use, as a fluorescent chromophore, of a compound with formula (I) wherein: A1 is —N— or —C(Y1)—; A2 is —N— or —C(Y2)—; A3 is —N— or —C(Y3)—; A4 is —N— or —C(Y4)—; at least one of A1, A2, A3 and A4 representing —N—; X1 is —N— or —C(Y5)—; X2 is —N— or —C(Y6)—; X3 is —N— or —C(Y7)—; and Y1, Y2, Y3, Y4, Y5, Y6 and Y7 are in particular chosen independently of one another from the group made up of: H, electron-donor groups and electron-attracting groups.
    Type: Application
    Filed: July 19, 2016
    Publication date: July 12, 2018
    Inventors: Franck SUZENET, Doina SIRBU, Gérald GUILLAUMET, Pascal BONNET
  • 1,4-DISUBSTITUTED 1,2,3-TRIAZOLES, METHODS FOR PREPARING SAME, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
    Publication number: 20140030191
    Abstract: A compound having the following general formula (I): wherein: X is a nitrogen atom and Y is a carbon atom; or X is a carbon atom and Y is a nitrogen atom; the Ar group is an aryl or heteroaryl group; and the RN and RN? groups, together with the carbon atoms to which they are bound, form a monocyclic or bicyclic azacycloalkane group. The pharmaceutically acceptable salts thereof, the hydrates or polymorphic crystalline structures thereof, and to the racemates, diastereoisomers, or enantiomers thereof are also described.
    Type: Application
    Filed: April 20, 2012
    Publication date: January 30, 2014
    Applicant: Centre National de la Recherche Scientifique (C.N.R.S.)
    Inventors: Sylvain Routier, Franck Suzenet, Frederic Pin, Sylvie Chalon, Johnny Vercouillie, Denis Guilloteau
  • Heterocyclic Oxime Compounds, Process for Their Preparation and Pharmaceutical Compositions Containing Them
    Publication number: 20090274674
    Abstract: Compounds of formula (I): wherein: X represents a hydrogen or halogen atom or an alkyl group, R1, R2, R3 and R4 are as defined in the description, A represents an alkylene chain as defined in the description, B represents an alkyl or alkenyl group substituted by a group D represents a pyridine nucleus.
    Type: Application
    Filed: December 19, 2006
    Publication date: November 5, 2009
    Applicant: LES LABORATOIRES SERVIER
    Inventors: Franck Suzenet, Gerald Guillaumet, Christelle Pillard, Carine Bassene, Catherine Dacquet, Alain Ktorza, Daniel-Henri Caignard